Skip to main content

AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips

A health worker administers a dose of the AstraZeneca COVID-19 vaccine to a man in Bangkok on Feb. 23, 2022. (Sakchai Lalit / AP Photo) A health worker administers a dose of the AstraZeneca COVID-19 vaccine to a man in Bangkok on Feb. 23, 2022. (Sakchai Lalit / AP Photo)
Share

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

(Reporting by Urvi Dugar, Maria Ponnezhath and Gursimran Kaur in Bengaluru; Editing by Pooja Desai)

CTVNews.ca Top Stories

Oilers rally to beat Stars, tie Western Conference Final

With the Edmonton Oilers down two goals late in the first period of Game 4, Rogers Place was quiet, fans seemingly bewildered at the early, quick scoring of the Dallas Stars and the slow start by the home team. Ryan McLeod's marker with six-and-a-half minutes in the opening frame left changed all that.

Local Spotlight